pe anti mouse cd90 antibody (Elabscience Biotechnology)
Structured Review
Pe Anti Mouse Cd90 Antibody, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd90+pe/PE+Anti-Mouse+CD90+Antibody/pmc12907102-324-17-24
Average 94 stars, based on 6 article reviews
Images
Related Articles
Staining:Article Title: Rg1-preconditioned adipose-derived mesenchymal stromal cells alleviate colitis via exosome-mediated Inhibition of macrophage glycolysis through RAS signaling Article Snippet: ADSCs at passages 3–5 were digested with 0.25% trypsin (BC-CE-002, Biochannel; free of EDTA and phenol red), centrifuged, and resuspended in cold PBS containing 0.1% BSA (BSA; A8020, Solarbio, China). .. After two washes (450 × g, 5 min), 1 × 106 cells were stained with fluorophore-conjugated antibodies—CD73-APC (E-AB-F1242E, Elabscience, Wuhan, China), Incubation:Article Title: Yam Carbon Dots Promote Bone Defect Repair by Modulating Histone Demethylase 4B Article Snippet: .. Next, the cells were incubated for 30 min at 4°C with anti-mouse CD34-FITC, Article Title: Mesenchymal stem cells transfected with anti-miRNA-204-3p inhibit acute rejection after heart transplantation by targeting C-X-C motif chemokine receptor 4 (CXCR4) in vitro Article Snippet: Transfection was performed using Lipofectamine ® 2000 (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA) according to the manufacturer’s protocol. .. These MSCs were then incubated with the fluorescently labeled antibodies CD11b-PE, CD44-APC, CD45-FITC, and Article Title: Yam Carbon Dots Promote Bone Defect Repair by Modulating Histone Demethylase 4B Article Snippet: .. Next, the cells were incubated for 30 min at 4°C with anti-mouse CD34-FITC, Article Title: Diabetic and nondiabetic BMSC-derived exosomes affect bone regeneration via regulating miR-17-5p/SMAD7 axis. Article Snippet: Diabetic bone disease (DBD) is a complication of diabetes mellitus (DM) and is characterized by impaired osteocyte function and delayed bone remodeling due to high blood glucose levels and sustained release of inflammatory factors.. Recent studies show that the regulation of osteoblasts (OBs) by bone marrow stromal cells (BMSCs) is an important mechanism in alleviating DBD and that exosomes are recognized as the key medium.. Mesenchymal stem cell–derived exosome (MSC-Exos) therapy is a promising approach to facilitate tissue repair. Labeling:Article Title: Mesenchymal stem cells transfected with anti-miRNA-204-3p inhibit acute rejection after heart transplantation by targeting C-X-C motif chemokine receptor 4 (CXCR4) in vitro Article Snippet: Transfection was performed using Lipofectamine ® 2000 (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA) according to the manufacturer’s protocol. .. These MSCs were then incubated with the fluorescently labeled antibodies CD11b-PE, CD44-APC, CD45-FITC, and Flow Cytometry:Article Title: Mesenchymal stem cells transfected with anti-miRNA-204-3p inhibit acute rejection after heart transplantation by targeting C-X-C motif chemokine receptor 4 (CXCR4) in vitro Article Snippet: Transfection was performed using Lipofectamine ® 2000 (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA) according to the manufacturer’s protocol. .. These MSCs were then incubated with the fluorescently labeled antibodies CD11b-PE, CD44-APC, CD45-FITC, and Suspension:Article Title: Diabetic and nondiabetic BMSC-derived exosomes affect bone regeneration via regulating miR-17-5p/SMAD7 axis. Article Snippet: Diabetic bone disease (DBD) is a complication of diabetes mellitus (DM) and is characterized by impaired osteocyte function and delayed bone remodeling due to high blood glucose levels and sustained release of inflammatory factors.. Recent studies show that the regulation of osteoblasts (OBs) by bone marrow stromal cells (BMSCs) is an important mechanism in alleviating DBD and that exosomes are recognized as the key medium.. Mesenchymal stem cell–derived exosome (MSC-Exos) therapy is a promising approach to facilitate tissue repair. |
